Analysts think CLRB stock price could increase by 1107%
Dec 25, 2024, 12:26 PM
-3.79%
What does CLRB do
Cellectar Biosciences, based in Florham Park, New Jersey, develops phospholipid drug conjugates for cancer treatment and imaging, with a focus on targeted therapies and a pipeline including iopofosine. The company went public on May 20, 2005, and employs 20 staff.
5 analysts think CLRB stock price will increase by 1107.10%. The current median analyst target is $3.06 compared to a current stock price of $0.25. The lowest analysts target is $1.01 and the highest analyst target is $13.65.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.